Urticaria
Summary
Urticaria (Hives) is a common condition characterised by itchy wheals (raised, erythematous, oedematous lesions) that result from mast cell degranulation and histamine release in the superficial dermis. Individual wheals are typically fleeting (resolve within 24 hours) and intensely itchy (not painful). Urticaria is classified as Acute (less than 6 weeks, often allergic or viral) or Chronic (≥6 weeks, most commonly Chronic Spontaneous Urticaria [CSU], often autoimmune). Angioedema (deeper dermal/submucosal swelling) may accompany urticaria. First-line treatment is non-sedating H1 antihistamines (Cetirizine, Fexofenadine, Loratadine), which can be increased up to 4x licensed dose in chronic refractory cases. Omalizumab (Anti-IgE antibody) is highly effective for severe CSU. Always exclude Anaphylaxis in acute presentations with systemic symptoms. [1,2]
Clinical Pearls
Fleeting Wheals (Each less than 24h): If individual lesions last >24 hours and are painful or leave bruising, consider Urticarial Vasculitis – different condition requiring investigation.
Chronic = Usually Autoimmune (CSU): Chronic Spontaneous Urticaria is often due to autoantibodies against IgE receptor. No external trigger found.
Up to 4x Antihistamine Dose: Standard dose often insufficient. Guidelines endorse increasing up to 4x licensed dose before escalating therapy.
Omalizumab Works: Anti-IgE monoclonal antibody is highly effective for CSU refractory to antihistamines.
Prevalence
- Lifetime Prevalence: ~20% (Very common).
- Acute Urticaria: Much more common than Chronic.
- Chronic Urticaria: ~1% of population. Female > Male (2:1).
Classification
| Type | Duration | Common Causes |
|---|---|---|
| Acute Urticaria | less than 6 weeks | Viral infection (Most common, especially in children). Allergic reaction (Food, Drug). Often idiopathic. |
| Chronic Urticaria | ≥6 weeks | Chronic Spontaneous Urticaria (CSU) – No identifiable trigger. Chronic Inducible Urticaria – Triggered by physical factors. |
Chronic Inducible Urticarias (Physical Urticarias)
| Subtype | Trigger |
|---|---|
| Dermographism | Stroking/Scratching skin. "Skin Writing". Very common. |
| Cholinergic Urticaria | Heat, Exercise, Sweating. Small (1-3mm) wheals. |
| Cold Urticaria | Cold exposure (Air, Water). Risk of anaphylaxis with cold water immersion. |
| Pressure Urticaria | Sustained pressure (Delayed). Painful. |
| Solar Urticaria | Sunlight exposure. |
| Aquagenic Urticaria | Water contact (Any temperature). Rare. |
Mechanism
- Mast Cell Activation: Trigger (IgE-mediated allergy, Autoantibodies, Physical stimulus, Unknown) activates cutaneous mast cells.
- Degranulation: Release of preformed mediators from mast cell granules.
- Histamine Release: Primary mediator. Causes vasodilation, increased vascular permeability, sensory nerve stimulation.
- Wheal Formation: Plasma extravasation into superficial dermis → Oedema → Raised, erythematous, oedematous lesion.
- Itch: Histamine stimulates cutaneous sensory nerves.
- Resolution: Wheals typically resolve within 24 hours as mediators are cleared.
Chronic Spontaneous Urticaria (CSU) – Autoimmune Mechanism
- Type I Autoimmune CSU: Autoantibodies against IgE itself.
- Type IIb Autoimmune CSU: Autoantibodies against the high-affinity IgE receptor (FcεRI) on mast cells → Direct mast cell activation.
- Explains why Omalizumab (Anti-IgE) is effective.
| Condition | Key Features |
|---|---|
| Urticaria | Wheals. Itchy. Each lesion lasts less than 24h. No bruising. Blanching. |
| Urticarial Vasculitis | Wheals last >24h. Painful (Not just itchy). Leaves Purpura/Bruising (Post-inflammatory hyperpigmentation). May have systemic symptoms (Fever, Arthralgia). Biopsy shows Leukocytoclastic vasculitis. |
| Anaphylaxis | Urticaria + Systemic symptoms: Hypotension, Bronchospasm, Angioedema (Airway). Emergency. |
| Angioedema without Urticaria | Deeper swelling (Lips, Face, Tongue, Genitals, Bowel). Consider Hereditary Angioedema (HAE) – C1-esterase inhibitor deficiency. Or ACEi-induced. |
| Erythema Multiforme | Target lesions. Fixed (Don't move). History of HSV or drug. |
| Bullous Pemphigoid (Prebullous) | Urticarial plaques. Elderly. Evolves to tense blisters. |
| Mastocytosis | Urticaria Pigmentosa – Tan/Brown macules that urticate on rubbing (Darier's Sign). Systemic symptoms. |
Wheals (The Hallmark)
| Feature | Description |
|---|---|
| Appearance | Raised, Oedematous, Erythematous. Central pallor may be present. Variable size (mm to cm). |
| Distribution | Any part of body. Often generalised. |
| Duration | Individual wheal lasts less than 24 hours (Usually 30 mins to few hours). May see new ones appearing as old resolve. |
| Itch | Intensely Itchy. Not painful (Pain suggests vasculitis). |
| Blanching | Wheals blanch on pressure (Unlike purpura). |
Angioedema (May Accompany ~50%)
Symptoms to Elicit
Acute Urticaria
- Usually No Investigations Needed: Self-limiting. History to identify trigger.
- Allergy Testing: Only if clear history suggests specific allergen (e.g., Food, Drug).
Chronic Urticaria (≥6 Weeks)
| Test | Rationale |
|---|---|
| FBC | Eosinophilia (Parasitic, Allergic). |
| ESR / CRP | Elevated in Urticarial Vasculitis. |
| TFTs | Thyroid autoimmunity associated with CSU. |
| Allergy Testing (Skin Prick / Specific IgE) | Low yield in CSU (Not usually IgE-mediated). Consider if history suggests allergy. |
| Complement (C3, C4, C1-Esterase Inhibitor) | If Angioedema without Urticaria or Family history → Exclude Hereditary Angioedema (HAE). |
| ANA | If vasculitis or connective tissue disease suspected. |
| Skin Biopsy | If lesions last >24h, Painful, or leave bruising – Exclude Urticarial Vasculitis. |
Challenge Tests (For Inducible Urticarias)
| Subtype | Test |
|---|---|
| Dermographism | Stroke skin with firm object. |
| Cold Urticaria | Ice cube test (Ice on forearm 5 mins). |
| Cholinergic | Exercise challenge. |
Management Algorithm
URTICARIA PRESENTATION
↓
EXCLUDE ANAPHYLAXIS
(Airway compromise, Hypotension, Systemic symptoms?)
┌────────────────┴────────────────┐
YES (ANAPHYLAXIS) NO
↓ ↓
EMERGENCY Rx ASSESS DURATION
- IM Adrenaline
- ABCDE ┌─────────────┴─────────────┐
- See Anaphylaxis ACUTE (less than 6 weeks) CHRONIC (≥6 weeks)
Pathway ↓ ↓
Often self-limiting CHRONIC SPONTANEOUS
+ H1 Antihistamine URTICARIA (CSU)
+ Identify/Avoid or INDUCIBLE
Trigger
↓
FIRST-LINE: NON-SEDATING H1 ANTIHISTAMINES
┌──────────────────────────────────────────────────────────┐
│ Cetirizine 10mg OD OR Fexofenadine 180mg OD OR │
│ Loratadine 10mg OD │
│ │
│ If inadequate control after 2-4 weeks: │
│ → INCREASE DOSE UP TO 4x LICENSED DOSE │
│ (e.g., Cetirizine 10mg QDS / Fexofenadine 180mg QDS) │
│ (Off-label but evidence-based and guideline endorsed) │
└──────────────────────────────────────────────────────────┘
↓
INADEQUATE RESPONSE TO 4x ANTIHISTAMINE?
┌────────────────┴────────────────┐
YES NO
↓ ↓
SECOND-LINE OPTIONS CONTINUE +
REVIEW PERIODICALLY
┌──────────────────────────────────────────────────────────┐
│ ADD Leukotriene Antagonist (Montelukast 10mg OD) │
│ - Modest benefit. Can try for 4 weeks. │
│ │
│ ADD H2 Antihistamine (Ranitidine 150mg BD - Note: │
│ Availability issues; Famotidine alternative) │
│ - Weak evidence. │
└──────────────────────────────────────────────────────────┘
↓
STILL REFRACTORY?
┌──────────────────────────────────────────────────────────┐
│ REFER TO DERMATOLOGY / ALLERGY │
│ │
│ THIRD-LINE: OMALIZUMAB (Xolair) │
│ - Anti-IgE Monoclonal Antibody. │
│ - 300mg SC every 4 weeks. │
│ - Highly effective for CSU (~70-80% respond). │
│ - Specialist initiation. │
│ │
│ OTHER OPTIONS (Specialist): │
│ - Ciclosporin (Immunosuppressant – Off-label). │
│ - Short course Oral Steroids (For acute flares ONLY – │
│ NOT long-term). │
└──────────────────────────────────────────────────────────┘
Treatment Summary
| Line | Treatment | Notes |
|---|---|---|
| 1st Line | Non-Sedating H1 Antihistamine (Standard Dose) | Cetirizine, Fexofenadine, Loratadine, Bilastine. |
| 1st Line (Escalated) | H1 Antihistamine up to 4x Dose | If suboptimal response. Off-label but guideline endorsed. |
| 2nd Line | Add Montelukast (Leukotriene Antagonist) | Modest benefit. |
| 3rd Line | Omalizumab (Anti-IgE) | Specialist. Highly effective for CSU. |
| Refractory | Ciclosporin (Immunosuppressant) | Specialist. Off-label. |
| Acute Flares Only | Short-course Oral Prednisolone | Max 3-5 days. Avoid long-term steroids. |
Avoid
- Long-term Oral Corticosteroids: Side effects outweigh benefits.
- Sedating Antihistamines (Chlorphenamine, Promethazine): Sedation, Anticholinergic effects. Avoid as first-line (May use at night in some cases).
| Complication | Notes |
|---|---|
| Anaphylaxis | If urticaria is part of systemic allergic reaction. Medical emergency. |
| Angioedema (Airway) | Tongue/Laryngeal swelling → Asphyxiation. |
| Quality of Life Impact | Chronic urticaria significantly impacts sleep, work, mood. |
| Underlying Disease | Urticarial Vasculitis may indicate Lupus or other CTD. |
- Acute Urticaria: Usually self-limiting (Days to weeks).
- Chronic Spontaneous Urticaria (CSU): Variable. ~50% resolve within 1-3 years. Some persist for years.
- Omalizumab: Excellent response rates (~70-80%). Symptoms may return on stopping.
Key Guidelines
| Guideline | Organisation | Key Recommendations |
|---|---|---|
| BSACI Urticaria Guidelines | BSACI | Non-sedating H1 antihistamines first-line. Up to 4x dose. Omalizumab for refractory CSU. |
| EAACI/GA²LEN/EDF/WAO Urticaria Guidelines | International (2022 Update) | Similar. Comprehensive grading system. |
What is Urticaria (Hives)?
Urticaria (also called "Hives" or "Nettle Rash") is a condition where you get itchy, raised, red bumps on the skin (called "wheals"). They can appear anywhere on the body and usually come and go quickly – each bump usually lasts less than 24 hours.
What causes it?
In many cases, no specific cause is found. Sometimes it's triggered by an allergy (food, medication), an infection (like a cold), or a physical factor (cold, heat, pressure). In chronic cases (lasting more than 6 weeks), the immune system often mistakenly triggers the skin reaction without an external cause.
Is it serious?
Usually, urticaria is uncomfortable but not dangerous. However, if you have swelling of the lips, tongue, or throat, or difficulty breathing, this is an emergency (anaphylaxis) – call 999.
How is it treated?
The main treatment is antihistamine tablets (like Cetirizine or Fexofenadine). You may need to take a higher dose than usual. Most cases get better over time, but some people need specialist treatments like Omalizumab (an injection).
Primary Sources
- Zuberbier T, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. PMID: 34536239.
- Powell RJ, et al. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015;45(3):547-65. PMID: 25711134.
Common Exam Questions
- Duration of Individual Wheal: "How long does each individual wheal last in typical urticaria?"
- Answer: less than 24 hours.
- Urticarial Vasculitis Clue: "What feature suggests Urticarial Vasculitis rather than simple Urticaria?"
- Answer: Wheals lasting >24 hours, Painful (not just itchy), Leave bruising/Purpura.
- First-Line Treatment: "First-line treatment for Chronic Spontaneous Urticaria?"
- Answer: Non-sedating H1 Antihistamine (Cetirizine, Fexofenadine, Loratadine), up to 4x licensed dose if needed.
- Third-Line Treatment: "Biologic therapy for refractory CSU?"
- Answer: Omalizumab (Anti-IgE Monoclonal Antibody).
Viva Points
- 4x Dose Antihistamines: Explain this is guideline-endorsed, off-label use.
- Dermographism Test: Demonstrate/describe.
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.